Healthcare provider profile · identity verified

Bindu Joseph, MD

Family Practice · WASHINGTON, DC · NPI 1518993559

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	847	140
Amlodipine Besylate	Amlodipine Besylate	824	169
Losartan Potassium	Losartan Potassium	347	70
Metoprolol Succinate	Metoprolol Succinate	300	47
Levothyroxine Sodium	Levothyroxine Sodium	299	59
Lisinopril	Lisinopril	291	46
Memantine Hcl	Memantine Hcl	288	40
Gabapentin	Gabapentin	253	48
Furosemide	Furosemide	240	57
Donepezil Hcl	Donepezil Hcl	226	35
Famotidine	Famotidine	210	48
Hydrochlorothiazide	Hydrochlorothiazide	191	44
Mirtazapine	Mirtazapine	184	37
Trazodone Hcl	Trazodone Hcl	184	29
Eliquis	Apixaban	176	43
Potassium Chloride	Potassium Chloride	175	25
Fluticasone Propionate	Fluticasone Propionate	154	67
Hydralazine Hcl	Hydralazine Hcl	152	37
Metformin Hcl	Metformin Hcl	151	37
Tamsulosin Hcl	Tamsulosin Hcl	149	24
Carvedilol	Carvedilol	148	29
Rosuvastatin Calcium	Rosuvastatin Calcium	138	31
Pantoprazole Sodium	Pantoprazole Sodium	129	36
Escitalopram Oxalate	Escitalopram Oxalate	123	18
Omeprazole	Omeprazole	120	28
Allopurinol	Allopurinol	113	26
Duloxetine Hcl	Duloxetine Hcl	112	22
Olanzapine	Olanzapine	112	16
Levetiracetam	Levetiracetam	111	15
Simvastatin	Simvastatin	109	30
Quetiapine Fumarate	Quetiapine Fumarate	99	21
Sertraline Hcl	Sertraline Hcl	97	20
Metoprolol Tartrate	Metoprolol Tartrate	91	20
Albuterol Sulfate Hfa	Albuterol Sulfate	90	34
Januvia	Sitagliptin Phosphate	80	15
Alendronate Sodium	Alendronate Sodium	76	20
Montelukast Sodium	Montelukast Sodium	68	16
Prednisone	Prednisone	62	34
Clopidogrel	Clopidogrel Bisulfate	59	16
Latanoprost	Latanoprost	59	19
Olmesartan Medoxomil	Olmesartan Medoxomil	58	11
Glipizide	Glipizide	56	suppressed
Citalopram Hbr	Citalopram Hydrobromide	54	suppressed
Ezetimibe	Ezetimibe	53	suppressed
Risperidone	Risperidone	53	suppressed
Tramadol Hcl	Tramadol Hcl	50	12
Pravastatin Sodium	Pravastatin Sodium	49	suppressed
Atenolol	Atenolol	48	suppressed
Xarelto	Rivaroxaban	48	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	47	18
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	47	14
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	45	11
Buspirone Hcl	Buspirone Hcl	45	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	41	suppressed
Diclofenac Sodium	Diclofenac Sodium	40	14
Clonidine	Clonidine	37	suppressed
Jardiance	Empagliflozin	37	suppressed
Myrbetriq	Mirabegron	37	suppressed
Pregabalin	Pregabalin	36	14
Alprazolam	Alprazolam	34	suppressed
Baclofen	Baclofen	34	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	33	suppressed
Chlorthalidone	Chlorthalidone	33	suppressed
Meloxicam	Meloxicam	33	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	32	suppressed
Amiodarone Hcl	Amiodarone Hcl	32	suppressed
Irbesartan	Irbesartan	31	suppressed
Nystatin	Nystatin	31	15
Lantus	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Clonazepam	Clonazepam	29	suppressed
Hydrocortisone	Hydrocortisone	28	12
Labetalol Hcl	Labetalol Hcl	28	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	27	19
Calcitriol	Calcitriol	27	suppressed
Divalproex Sodium	Divalproex Sodium	27	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	26	suppressed
Lactulose	Lactulose	26	12
Nifedipine Er	Nifedipine	26	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	25	suppressed
Lidocaine	Lidocaine	25	suppressed
Spironolactone	Spironolactone	25	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Torsemide	Torsemide	24	suppressed
Orencia	Abatacept	23	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	23	suppressed
Ozempic	Semaglutide	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	suppressed
Cephalexin	Cephalexin	21	16
Finasteride	Finasteride	21	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	20	suppressed
Naproxen	Naproxen	20	17
Lacosamide	Lacosamide	19	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	16
Flecainide Acetate	Flecainide Acetate	18	suppressed
Humalog Kwikpen U-100	Insulin Lispro	18	suppressed
Metformin Hcl Er	Metformin Hcl	18	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Aranesp	Darbepoetin Alfa In Polysorbat	16	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Bumetanide	Bumetanide	16	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	16	suppressed
Eplerenone	Eplerenone	16	suppressed
Folic Acid	Folic Acid	16	suppressed
Midodrine Hcl	Midodrine Hcl	16	suppressed
Timolol Maleate	Timolol Maleate	16	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	16	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	15	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	15	suppressed
Divalproex Sodium Er	Divalproex Sodium	15	suppressed
Methimazole	Methimazole	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Santyl	Collagenase Clostridium Hist.	15	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Colesevelam Hcl	Colesevelam Hcl	14	suppressed
Erythromycin	Erythromycin Base	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Primidone	Primidone	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Propylthiouracil	Propylthiouracil	14	suppressed
Restasis	Cyclosporine	14	suppressed
Spiriva Handihaler	Tiotropium Bromide	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Albuterol Sulfate	Albuterol Sulfate	13	suppressed
Amantadine	Amantadine Hcl	13	suppressed
Carbidopa-Levodopa-Entacapone	Carbidopa/Levodopa/Entacapone	13	suppressed
Colchicine	Colchicine	13	suppressed
Copaxone	Glatiramer Acetate	13	suppressed
Itraconazole	Itraconazole	13	suppressed
Ketorolac Tromethamine	Ketorolac Tromethamine	13	suppressed
Methenamine Hippurate	Methenamine Hippurate	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Ssd	Silver Sulfadiazine	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Azithromycin	Azithromycin	12	12
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	12	suppressed
Entacapone	Entacapone	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Novolog	Insulin Aspart	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Silver Sulfadiazine	Silver Sulfadiazine	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Budesonide	Budesonide	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Juluca	Dolutegravir/Rilpivirine	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Rocklatan	Netarsudil Mesylat/Latanoprost	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error